Delivery Order SPE2DB22D3301-SPE2DB25FX9MC
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.82 firm-fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,075.80 firm-fixed-price delivery order is for the supply of Lyrica 150 mg capsules, a prescription medication used to treat nerve pain. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,965.12 firm fixed-price contract is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract is not designated with a set-aside requirement, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.13 firm fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,166.99 firm fixed price delivery order is for the supply of Lyrica 75 mg capsules, a medication used for various conditions including neuropathic pain, fibromyalgia, and epilepsy. The contract has an ultimate completion date of November 20, 2024 and there is no set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,040.28 firm fixed-price delivery order is for the supply of Lyrica 100 mg capsules, a medication used to treat various conditions such as neuropathic pain, fibromyalgia, and seizures. The contract is not designated as a set-aside award, indicating open competition. It is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,967.59 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules, a medication used to treat certain types of nerve pain. The contract has a period of performance through February 19, 2025 and was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,281.97 firm fixed-price delivery order contract covers the supply of LYRICA 100 mg capsules, a prescription medication primarily used to treat neuropathic pain. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $2,905.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Lyrica 300 mg capsules, a medication used for the treatment of neuropathic pain, nerve pain, and fibromyalgia. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,659.58 firm fixed-price delivery order is for the provision of 100 mg Lyrica capsules. The contract has an ultimate completion date of January 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FX9MCDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,430.77 firm fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat neuropathic pain. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA IDC, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 2/3/25 |